So they are already a share holder, so perhaps they never sold out completely?
Pfizer held approx 12% of the company in approx 2009.
Worked with Neuren on Glypormate.
There is history there, also Virginie Durez senior director product development spent 17 years with Pfizer
Cant help but think Pfizer will want Trof and nz-2591 in all indications....
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjGobSUrez1AhXhumMGHaifBJsQFnoECBoQAQ&url=https%3A%2F%2Fwww.biospace.com%2Farticle%2Freleases%2Fneuren-pharmaceuticals-limited-selects-new-compound-targeted-for-the-oral-treatment-of-parkinson-s-and-related-neurological-diseases-%2F&usg=AOvVaw24PAkj_7DbnqThzQW0igpi
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwj01qLhruz1AhXj4zgGHc4IAXEQFnoECBkQAQ&url=https%3A%2F%2Fwww.chegg.com%2Fhomework-help%2Fquestions-and-answers%2Fquestion-3-gly-pro-glu-glypromate-neuroprotective-compound-originally-developed-university-q64702730&usg=AOvVaw3qjKsCO9prVobl_tL9maX4
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwj01qLhruz1AhXj4zgGHc4IAXEQFnoECBYQAQ&url=https%3A%2F%2Fitprospt.com%2Fnum%2F7094852%2Fquestion-3gly-pro-glu-glypromate-is-a-neuroprotective-compound&usg=AOvVaw2wgW07p-et7M_nGHGp9Aaj
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$15.17 |
Change
-0.220(1.43%) |
Mkt cap ! $1.888B | |||
| Open | High | Low | Value | Volume |
| $15.45 | $15.45 | $15.03 | $6.517M | 428.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7052 | $15.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.20 | 199 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |